ADDINEX TECHNOLOGIES, INC.
NEW YORK, NY · Founded 2017 · CIK 0001750306 · Medtech · Private
Medication dispensing device with smartphone-controlled access, real-time monitoring, and patient education integration for clinical trials
- Grants
- $868K
- 4 awards
- Sector median: 1
- Raised
- $1.5M
- 3 Form D · Feb 2021
- 68 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $1,500,000 | |
| Private capital raised | Form D · SEC | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD) | $259,559 | |
| Federal grant | Department of Health and Human Services · Phase I · Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients | $295,906 | |
| Federal grant | Department of Health and Human Services · Phase I · Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients | $6,500 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Medication Adherence and Monitoring System Supporting Decentralized Clinical Trials for Substance Use Disorder | $306,528 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1925 | BIOSYNTAGMA, LLC | — | — |
| 1926 | WEARABLE DEFENSE LLC | — | — |
| 1927 | SEER, INC. | — | — |
| 1928 | ADDINEX TECHNOLOGIES, INC. | — | $1.5M |
| 1929 | ViaLase, Inc. | — | $76M |
| 1930 | R3 Vascular Inc. | — | $75M |
| 1931 | Medical Innovation Through Technology, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- David ElliotExecutive Officer
- Patrick HolwayPromoter
- Stanislav RoslyakovDirector · Executive Officer
- Jay SchiffDirector · Executive Officer
Patents
- Prescription Drug Abuse Prevention Systemgranted
- Prescription Drug Abuse Prevention Systemapplication
- Prescription Drug Abuse Prevention Systemapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.